Univariate analysis | Â | Â | Multivariate analysis (baseline model)* | Multivariate analysis (final model)* | ||
---|---|---|---|---|---|---|
Variable | OR (95% CI) | p | Adjusted OR (95% CI) | p | Adjusted OR (95% CI) | p |
Sex (female vs male) | 1.72 (0.81–3.62) | 0.16 | 1.90 (0.86–4.20) | 0.11 | – | – |
Diagnosis (PsA vs RA) | 0.87 (0.38–1.98) | 0.7 | – | – | – | – |
Current biologic DMARD | 0.44 (0.23–0.82) | 0.01 | 0.42 (0.21–0.82) | 0.01 | 0.36 (0.19–0.71) | 0.003 |
Current methotrexate | 1.12 (0.61–2.06) | 0.7 | – | – | – | – |
Current prednis(ol)one | 0.82 (0.43–1.57) | 0.6 | – | – | – | – |
Current hypertension | 1.63 (0.88–3.04) | 0.12 | 1.26 (0.63–2.51) | 0.51 | – | – |
Current hyperlipidaemia | 2.08 (1.07–4.06) | 0.03 | 2.06 (0.99–4.31) | 0.05 | 2.20 (1.09–4.44) | 0.03 |
Current diabetes | 1.60 (0.60–4.31) | 0.4 | – | – | – | – |
Current smoker | 0.73 (0.16–3.42) | 0.7 | – | – | – | – |
Overweight or obese | 3.91 (1.76–8.67) | 0.001 | 4.08 (1.76–9.47) | 0.001 | 4.49 (1.97–10.26) | < 0.001 |
University/tertiary education | 0.94 (0.52–1.72) | 0.9 | – | – | – | – |
Full time work or study | 0.94 (0.48–1.85) | 0.9 | – | – | – | – |
Age ≥ 65 years | 1.10 (0.59–2.08) | 0.8 | – | – | – | – |
Disease duration ≥5 years | 1.33 (0.37–4.73) | 0.7 | – | – | – | – |
Self-reported low disease activity (VAS ≤ 20) | 0.43 (0.22–0.87) | 0.02 | 0.55 (0.26–1.16) | 0.12 | – | – |
Low pain (VAS ≤20) | 0.46 (0.22–0.94) | 0.03 | – | – | – | – |